Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis
β Scribed by Kazuma Ohyashiki; Isayo Sasao; Junko H. Ohyashiki; Tomofumi Murakami; Atsuhiro Iwabuchi; Tetsuzo Tauchi; Keisuke Toyama; Midori Saito; Shinpei Nakazawa; Hiromi Serizawa; Yoshiro Ebihara
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 528 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A total of 109 patients with myelodysplastic syndromes (MDS) was analyzed to determine the clinical and pathologic features of the five recently defined French-American-British Cooperative Group (FAB) subtypes, and to assess the utility of this classification system in predicting survival, evolution
The myelodysplastic syndromes (MDS) are clonal hematologic malignancies characterized by pancytopenia, dysplastic hematopoiesis, and a propensity to leukemic transformation. Increased apoptosis has been noted in MDS as a possible explanation for ineffective hematopoiesis, with lower levels in progre
The FAB group has defined myelodysplasia in adults but direct application of this categorization to children has been controversial. Consequently, to outline the natural history of the disease better we have retrospectively analysed case reports and series published in English between 1982 and 1996.
## Abstract We studied the effects of the presence of the HLAβDR15 allele on the experimental and clinical features of myelodysplastic syndrome (MDS) by assessing the clinical data of 136 patients with MDS. We observed that the frequency of HLAβDR15 expression in MDS patients (38.7%) was significan